Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.

Giri B, Gupta VK, Yaffe B, Modi S, Roy P, Sethi V, Lavania SP, Vickers SM, Dudeja V, Banerjee S, Watts J, Saluja A.

J Transl Med. 2019 Sep 4;17(1):301. doi: 10.1186/s12967-019-2048-3.

2.

O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability.

Sharma NS, Gupta VK, Dauer P, Kesh K, Hadad R, Giri B, Chandra A, Dudeja V, Slawson C, Banerjee S, Vickers SM, Saluja A, Banerjee S.

Theranostics. 2019 May 24;9(12):3410-3424. doi: 10.7150/thno.32615. eCollection 2019.

3.

Correction: Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.

Banerjee S, Sangwan V, McGinn O, Chugh R, Dudeja V, Vickers SM, Saluja AK.

J Biol Chem. 2019 Jul 5;294(27):10739. doi: 10.1074/jbc.AAC119.009844. No abstract available.

4.

Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.

Giri B, Gupta VK, Yaffe B, Modi S, Roy P, Sethi V, Lavania SP, Vickers SM, Dudeja V, Banerjee S, Watts J, Saluja A.

J Transl Med. 2019 May 20;17(1):163. doi: 10.1186/s12967-019-1901-8. Erratum in: J Transl Med. 2019 Sep 4;17(1):301.

5.

African American Men's Health: Research, Practice, and Policy.

Shikany JM, Schoenberger YM, Konety BR, Vickers SM.

Am J Prev Med. 2018 Nov;55(5 Suppl 1):S1-S4. doi: 10.1016/j.amepre.2018.07.011. No abstract available.

6.

Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.

Sethi V, Kurtom S, Tarique M, Lavania S, Malchiodi Z, Hellmund L, Zhang L, Sharma U, Giri B, Garg B, Ferrantella A, Vickers SM, Banerjee S, Dawra R, Roy S, Ramakrishnan S, Saluja A, Dudeja V.

Gastroenterology. 2018 Jul;155(1):33-37.e6. doi: 10.1053/j.gastro.2018.04.001. Epub 2018 Apr 7.

7.

Strategic Partnerships in Surgery: A Model for the US.

Vickers SM.

J Am Coll Surg. 2018 Apr;226(4):345-354. doi: 10.1016/j.jamcollsurg.2017.12.053. Epub 2018 Feb 13. No abstract available.

PMID:
29452229
8.

Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.

Dauer P, Zhao X, Gupta VK, Sharma N, Kesh K, Gnamlin P, Dudeja V, Vickers SM, Banerjee S, Saluja A.

Cancer Res. 2018 Mar 1;78(5):1321-1333. doi: 10.1158/0008-5472.CAN-17-2320. Epub 2017 Dec 19.

9.

GRIT and Resilience: Keys to the Development of the Halsted Resident in the John Cameron Era.

Vickers SM, Vickers AL.

Ann Surg. 2018 Feb;267(2S Suppl 2):S22-S25. doi: 10.1097/SLA.0000000000002530. No abstract available.

PMID:
29194084
10.

Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials.

Niranjan SJ, Durant RW, Wenzel JA, Cook ED, Fouad MN, Vickers SM, Konety BR, Rutland SB, Simoni ZR, Martin MY.

J Cancer Educ. 2019 Feb;34(1):26-34. doi: 10.1007/s13187-017-1261-0.

PMID:
28776305
11.

Racial disparities in length-of-stay persist even with no postoperative complications.

Giglia MD, DeRussy A, Morris MS, Richman JS, Hawn MT, Vickers SM, Knight SJ, Chu DI.

J Surg Res. 2017 Jun 15;214:14-22. doi: 10.1016/j.jss.2017.02.063. Epub 2017 Mar 6.

PMID:
28624035
12.

Enhanced Recovery After Surgery (ERAS) Eliminates Racial Disparities in Postoperative Length of Stay After Colorectal Surgery.

Wahl TS, Goss LE, Morris MS, Gullick AA, Richman JS, Kennedy GD, Cannon JA, Vickers SM, Knight SJ, Simmons JW, Chu DI.

Ann Surg. 2018 Dec;268(6):1026-1035. doi: 10.1097/SLA.0000000000002307.

PMID:
28594746
13.

Erratum to: A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers.

Simoni ZR, Martin MY, Wenzel J, Cook ED, Konety B, Vickers SM, Chen MS Jr, Foaud MN, Durant RW.

J Racial Ethn Health Disparities. 2017 Oct;4(5):999. doi: 10.1007/s40615-017-0337-1. No abstract available.

PMID:
28127675
14.

A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers.

Simoni ZR, Martin M, Wenzel JA, Cook ED, Konety B, Vickers SM, Chen MS, Foaud MN, Durant RW.

J Racial Ethn Health Disparities. 2016 Nov 8. doi: 10.1007/s40615-016-0303-3. [Epub ahead of print] Erratum in: J Racial Ethn Health Disparities. 2017 Jan 27;:.

15.

Lessons Learned from Mentors and Heroes on Leadership and Surgical Resilience.

Vickers SM, Vickers AL.

J Gastrointest Surg. 2017 Jan;21(1):1-11. doi: 10.1007/s11605-016-3257-1. Epub 2016 Oct 17. No abstract available.

PMID:
27752807
16.

RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.

Kirby MK, Ramaker RC, Gertz J, Davis NS, Johnston BE, Oliver PG, Sexton KC, Greeno EW, Christein JD, Heslin MJ, Posey JA, Grizzle WE, Vickers SM, Buchsbaum DJ, Cooper SJ, Myers RM.

Mol Oncol. 2016 Oct;10(8):1169-82. doi: 10.1016/j.molonc.2016.05.004. Epub 2016 May 26.

17.

Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials.

Fouad MN, Acemgil A, Bae S, Forero A, Lisovicz N, Martin MY, Oates GR, Partridge EE, Vickers SM.

J Oncol Pract. 2016 Jun;12(6):556-63. doi: 10.1200/JOP.2015.008946. Epub 2016 May 17.

18.

Disposition of the Dietary Mutagen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in Healthy and Pancreatic Cancer Compromised Humans.

Malfatti MA, Kuhn EA, Turteltaub KW, Vickers SM, Jensen EH, Strayer L, Anderson KE.

Chem Res Toxicol. 2016 Mar 21;29(3):352-8. doi: 10.1021/acs.chemrestox.5b00495. Epub 2016 Mar 8.

19.

Nanostructured Materials Prepared by Surface-Assisted Reduction: New Catalysts for Methane Oxidation.

Gomathi A, Vickers SM, Gholami R, Alyani M, Man RW, MacLachlan MJ, Smith KJ, Wolf MO.

ACS Appl Mater Interfaces. 2015 Sep 2;7(34):19268-73. doi: 10.1021/acsami.5b05189. Epub 2015 Aug 19.

PMID:
26287568
20.

Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo.

Kimbrough CW, Khanal A, Zeiderman M, Khanal BR, Burton NC, McMasters KM, Vickers SM, Grizzle WE, McNally LR.

Clin Cancer Res. 2015 Oct 15;21(20):4576-85. doi: 10.1158/1078-0432.CCR-15-0314. Epub 2015 Jun 29.

21.

Mesoporous Mn- and La-doped cerium oxide/cobalt oxide mixed metal catalysts for methane oxidation.

Vickers SM, Gholami R, Smith KJ, MacLachlan MJ.

ACS Appl Mater Interfaces. 2015 Jun 3;7(21):11460-6. doi: 10.1021/acsami.5b02367. Epub 2015 May 22.

PMID:
26000732
22.

Primary and liver metastasis-derived cell lines from KrasG12D; Trp53R172H; Pdx-1 Cre animals undergo apoptosis in response to triptolide.

Sangwan V, Banerjee S, Jensen KM, Chen Z, Chugh R, Dudeja V, Vickers SM, Saluja AK.

Pancreas. 2015 May;44(4):583-9. doi: 10.1097/MPA.0000000000000317.

23.

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer.

Nomura A, Banerjee S, Chugh R, Dudeja V, Yamamoto M, Vickers SM, Saluja AK.

Oncotarget. 2015 Apr 10;6(10):8313-22.

24.

Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer.

LaRocca CJ, Han J, Gavrikova T, Armstrong L, Oliveira AR, Shanley R, Vickers SM, Yamamoto M, Davydova J.

Surgery. 2015 May;157(5):888-98. doi: 10.1016/j.surg.2015.01.006. Epub 2015 Feb 27.

25.

Lean and learn: applying the principles of lean in the ED.

Vickers SM.

Nursing. 2014 Dec;44(12):18-20. doi: 10.1097/01.NURSE.0000456381.25402.d4. No abstract available.

PMID:
25406776
26.

Sorafenib and triptolide as combination therapy for hepatocellular carcinoma.

Alsaied OA, Sangwan V, Banerjee S, Krosch TC, Chugh R, Saluja A, Vickers SM, Jensen EH.

Surgery. 2014 Aug;156(2):270-9. doi: 10.1016/j.surg.2014.04.055. Epub 2014 Jun 19.

PMID:
24953273
27.

Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells.

Mujumdar N, Banerjee S, Chen Z, Sangwan V, Chugh R, Dudeja V, Yamamoto M, Vickers SM, Saluja AK.

Am J Physiol Gastrointest Liver Physiol. 2014 Jun 1;306(11):G1011-20. doi: 10.1152/ajpgi.00466.2013. Epub 2014 Apr 3.

28.

Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway.

Chen Z, Sangwan V, Banerjee S, Chugh R, Dudeja V, Vickers SM, Saluja AK.

Cancer Lett. 2014 Jun 28;348(1-2):156-66. doi: 10.1016/j.canlet.2014.03.016. Epub 2014 Mar 21.

29.

Long-term outcomes of total pancreatectomy and islet auto transplantation for hereditary/genetic pancreatitis.

Chinnakotla S, Radosevich DM, Dunn TB, Bellin MD, Freeman ML, Schwarzenberg SJ, Balamurugan AN, Wilhelm J, Bland B, Vickers SM, Beilman GJ, Sutherland DE, Pruett TL.

J Am Coll Surg. 2014 Apr;218(4):530-43. doi: 10.1016/j.jamcollsurg.2013.12.037. Epub 2014 Jan 10.

30.

Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.

Hawk ET, Habermann EB, Ford JG, Wenzel JA, Brahmer JR, Chen MS Jr, Jones LA, Hurd TC, Rogers LM, Nguyen LH, Ahluwalia JS, Fouad M, Vickers SM.

Cancer. 2014 Apr 1;120 Suppl 7:1113-21. doi: 10.1002/cncr.28571.

32.

CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.

Banerjee S, Nomura A, Sangwan V, Chugh R, Dudeja V, Vickers SM, Saluja A.

Clin Cancer Res. 2014 May 1;20(9):2388-99. doi: 10.1158/1078-0432.CCR-13-2947. Epub 2014 Mar 14.

33.

Islet size index as a predictor of outcomes in clinical islet autotransplantation.

Suszynski TM, Wilhelm JJ, Radosevich DM, Balamurugan AN, Sutherland DE, Beilman GJ, Dunn TB, Chinnakotla S, Pruett TL, Vickers SM, Hering BJ, Papas KK, Bellin MD.

Transplantation. 2014 Jun 27;97(12):1286-91. doi: 10.1097/01.TP.0000441873.35383.1e.

34.

Total pancreatectomy and islet autotransplantation in children for chronic pancreatitis: indication, surgical techniques, postoperative management, and long-term outcomes.

Chinnakotla S, Bellin MD, Schwarzenberg SJ, Radosevich DM, Cook M, Dunn TB, Beilman GJ, Freeman ML, Balamurugan AN, Wilhelm J, Bland B, Jimenez-Vega JM, Hering BJ, Vickers SM, Pruett TL, Sutherland DE.

Ann Surg. 2014 Jul;260(1):56-64. doi: 10.1097/SLA.0000000000000569.

35.

Operative report teaching and synoptic operative reports: a national survey of surgical program directors.

Melton GB, Burkart NE, Frey NG, Chipman JG, Rothenberger DA, Vickers SM.

J Am Coll Surg. 2014 Jan;218(1):113-8. doi: 10.1016/j.jamcollsurg.2013.09.004. Epub 2013 Nov 6.

PMID:
24210148
36.

Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.

Rousalova I, Banerjee S, Sangwan V, Evenson K, McCauley JA, Kratzke R, Vickers SM, Saluja A, D'Cunha J.

PLoS One. 2013 Oct 15;8(10):e77411. doi: 10.1371/journal.pone.0077411. eCollection 2013.

37.

Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.

Banerjee S, Sangwan V, McGinn O, Chugh R, Dudeja V, Vickers SM, Saluja AK.

J Biol Chem. 2013 Nov 22;288(47):33927-38. doi: 10.1074/jbc.M113.500983. Epub 2013 Oct 15. Erratum in: J Biol Chem. 2019 Jul 5;294(27):10739.

38.

Surgical care and career opportunities in a changing practice paradigm.

Tepas JJ 3rd, Hughes TG Sr, Aaronson DS, Kesler JL, Buckley RJ, Dippolito AJ, Wall MJ, Merchant NB, Dandridge WC, Sinanan MN, Buchbinder D, Sussman HL, Hayes-Jordan A, Chen JC, Wetstein L, Arbutina DR, Dennehy JC 3rd, Alseidi A, Rege RV, Fink AS, Barney LM, Cloyd DW, Fallat ME, Loeff DS, Behrns KE, Vickers SM.

J Am Coll Surg. 2013 Oct;217(4):711-717.e1. doi: 10.1016/j.jamcollsurg.2013.05.031. No abstract available.

PMID:
24054411
39.

miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death.

Chen Z, Sangwan V, Banerjee S, Mackenzie T, Dudeja V, Li X, Wang H, Vickers SM, Saluja AK.

Mol Cancer. 2013 Sep 11;12(1):105. doi: 10.1186/1476-4598-12-105.

40.

A single intraduodenal administration of human adenovirus 40 vaccine effectively prevents anaphylactic shock.

Yamasaki S, Miura Y, Davydova J, Vickers SM, Yamamoto M.

Clin Vaccine Immunol. 2013 Oct;20(10):1508-16. doi: 10.1128/CVI.00417-13. Epub 2013 Jul 24.

41.

Total pancreatectomy with islet autotransplantation in patients with malignancy: are we there yet?

Dudeja V, Beilman GJ, Vickers SM.

Ann Surg. 2013 Aug;258(2):219-20. doi: 10.1097/SLA.0b013e31829c4a1b. No abstract available.

PMID:
23838892
42.

Disparities in pancreas cancer care.

Abraham A, Al-Refaie WB, Parsons HM, Dudeja V, Vickers SM, Habermann EB.

Ann Surg Oncol. 2013 Jun;20(6):2078-87. doi: 10.1245/s10434-012-2843-z. Epub 2013 Apr 12.

PMID:
23579872
43.

Cancer surgery among American Indians.

Markin A, Habermann EB, Zhu Y, Abraham A, Ahluwalia JS, Vickers SM, Al-Refaie WB.

JAMA Surg. 2013 Mar;148(3):277-84; discussion 284. doi: 10.1001/jamasurg.2013.1423.

PMID:
23552658
44.

Neoadjuvant interferon-based chemoradiation for borderline resectable and locally advanced pancreas cancer: a Phase II pilot study.

Jensen EH, Armstrong L, Lee C, Tuttle TM, Vickers SM, Sielaff T, Greeno EW.

HPB (Oxford). 2014 Feb;16(2):131-9. doi: 10.1111/hpb.12086. Epub 2013 Mar 19.

45.

Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity.

Krosch TC, Sangwan V, Banerjee S, Mujumdar N, Dudeja V, Saluja AK, Vickers SM.

Am J Surg. 2013 Apr;205(4):387-96. doi: 10.1016/j.amjsurg.2013.01.008. Epub 2013 Feb 19.

PMID:
23428154
46.

Does enrollment in cancer trials improve survival?

Chow CJ, Habermann EB, Abraham A, Zhu Y, Vickers SM, Rothenberger DA, Al-Refaie WB.

J Am Coll Surg. 2013 Apr;216(4):774-80; discussion 780-1. doi: 10.1016/j.jamcollsurg.2012.12.036. Epub 2013 Feb 13.

47.

Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer.

Groth SS, Al-Refaie WB, Zhong W, Vickers SM, Maddaus MA, D'Cunha J, Habermann EB.

Ann Thorac Surg. 2013 Apr;95(4):1221-6. doi: 10.1016/j.athoracsur.2012.10.079. Epub 2013 Feb 14.

PMID:
23415239
48.

Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer.

Yamasaki S, Miura Y, Davydova J, Vickers SM, Yamamoto M.

Int J Cancer. 2013 Jul;133(1):88-97. doi: 10.1002/ijc.27983. Epub 2012 Dec 21.

49.

Governors' Committee on Socioeconomic Issues.

Vickers SM.

Bull Am Coll Surg. 2012 Oct;97(10):51-3. No abstract available.

PMID:
23115886
50.

A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.

Chugh R, Sangwan V, Patil SP, Dudeja V, Dawra RK, Banerjee S, Schumacher RJ, Blazar BR, Georg GI, Vickers SM, Saluja AK.

Sci Transl Med. 2012 Oct 17;4(156):156ra139. doi: 10.1126/scitranslmed.3004334.

Supplemental Content

Loading ...
Support Center